🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, open-label, adaptive, repeat-dose study to evaluate ...
Status
Completed
Location
Vanda Investigational Site
Start Date
2021-01-13
Trial ID
NCT04712734
Treatments Being Tested
Evaluate the clinical outcome of two switching strategies to iloperidone tr...
Status
Completed
Location
Birmingham Psychiatry Pharmaceutical Studies, Inc.
Start Date
2010-08
Trial ID
NCT01207414
Treatments Being Tested
This is an open-label, sequential cohorts, flexible dose study to evaluate ...
Status
Withdrawn
Location
Vanda Investigational Site
Start Date
2022-06
Trial ID
NCT05344365
Treatments Being Tested
To evaluate the safety and tolerability of iloperidone in adolescent patien...
Status
Recruiting
Location
Vanda Investigational Site
Start Date
2023-05-24
Trial ID
NCT05648591
Treatments Being Tested
This is a single-center open-label study to be conducted in the United Stat...
Status
Completed
Location
Vanda Investigational Site
Start Date
2019-10-07
Trial ID
NCT04127058
Treatments Being Tested
to inspect relevant pharmacokinetic parameters and relative exploitation de...
Status
Unknown
Location
The first affiliated hospital of zhengzhou university.
Start Date
2017-11-17
Trial ID
NCT03420534
Treatments Being Tested
1. To assess the acute and long-term bimodal efficacy of iloperidone (IL), ...
Status
Completed
Location
UT Health Science Center San Antonio
Start Date
2012-04
Trial ID
NCT02413918
Treatments Being Tested
This is a single center, two-period, randomized study to evaluate the Bioeq...
Status
Completed
Location
Vanda Investigational Site
Start Date
2021-06-30
Trial ID
NCT04969211
Treatments Being Tested
Tolerability, undertstanding of the action of the drug in the body, and und...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-10
Trial ID
NCT01495169
Treatments Being Tested
Study to compare the pharmacokinetics and pharmacodynamics of VHX-896 and i...
Status
Completed
Location
Vanda Investigational Site
Start Date
2024-07-11
Trial ID
NCT06494397
Treatments Being Tested